Get the Stockscreener App
2.44
0.41%
0.010
Alzamend Neuro Inc stock is traded at $2.44, with a volume of 73,379.
It is up +0.41% in the last 24 hours and down -6.15% over the past month.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
See More
Previous Close:
$2.43
Open:
$2.4
24h Volume:
73,379
Relative Volume:
0.05
Market Cap:
$7.07M
Revenue:
-
Net Income/Loss:
$-5.85M
P/E Ratio:
-0.3648
EPS:
-6.6877
Net Cash Flow:
$-8.00M
1W Performance:
-2.01%
1M Performance:
-6.15%
6M Performance:
-67.63%
1Y Performance:
-88.16%
1-Day Range:
$2.37
$2.52
1-Week Range:
$2.37
$2.5294
52-Week Range:
$2.06
$24.93
Alzamend Neuro Inc Stock (ALZN) Company Profile
Name
Alzamend Neuro Inc
Sector
Industry
Phone
844-722-6333
Address
3500 LENOX RD. NE, ATLANTA
Compare ALZN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
2.44 | 7.63M | 0 | -5.85M | -8.00M | -6.6877 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-21 | Initiated | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc Stock (ALZN) Latest News
Sentiment analysis tools applied to Alzamend Neuro Inc.July 2025 Volume & Consistent Growth Equity Picks - Newser
Momentum Indicator Shows Bearish Divergence in Alzamend Neuro Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Should you hold or exit Alzamend Neuro Inc. nowEarnings Risk Report & Daily Growth Stock Tips - Newser
Volatility clustering patterns for Alzamend Neuro Inc.July 2025 Market Mood & Real-Time Chart Pattern Alerts - Newser
Is Alzamend Neuro Inc. impacted by rising ratesMarket Growth Report & Fast Moving Market Watchlists - kpenews.com
Regression analysis insights on Alzamend Neuro Inc. performance2025 Macro Impact & Daily Stock Momentum Reports - Newser
Using RSI to spot recovery in Alzamend Neuro Inc.2025 Bull vs Bear & Expert-Curated Trade Recommendations - Newser
What machine learning models say about Alzamend Neuro Inc.July 2025 Macro Moves & Accurate Intraday Trade Tips - Newser
Will Alzamend Neuro Inc. continue its uptrendBear Alert & Growth Focused Investment Plans - Newser
How to use Fibonacci retracement on Alzamend Neuro Inc.Quarterly Trade Review & Reliable Breakout Forecasts - Newser
Is Alzamend Neuro Inc. stock ready for a breakoutJuly 2025 Decliners & Real-Time Market Sentiment Alerts - Newser
Is Alzamend Neuro Inc. showing insider buyingGold Moves & Low Risk Investment Opportunities - kpenews.com
Alzamend Neuro Inc. stock momentum explainedJuly 2025 Retail & Verified Momentum Stock Watchlist - Newser
What technical models suggest about Alzamend Neuro Inc.’s comebackTrade Risk Report & AI Enhanced Trade Execution Alerts - Newser
How to recover losses in Alzamend Neuro Inc. stock2025 EndofYear Setup & Precise Swing Trade Alerts - Newser
Can technical indicators confirm Alzamend Neuro Inc.’s reversalJuly 2025 Weekly Recap & Weekly High Potential Alerts - Newser
Elliott Wave Theory Predicts Pullback in Alzamend Neuro Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Is This the Dip to Buy in Alzamend Neuro Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Applying Elliott Wave Theory to Alzamend Neuro Inc.Options Play & Free Growth Oriented Trading Recommendations - Newser
Will Alzamend Neuro Inc. stock recover after recent dropWeekly Trade Analysis & Risk Controlled Swing Alerts - Newser
Published on: 2025-08-29 18:45:48 - Newser
Key resistance and support levels for Alzamend Neuro Inc.Bear Alert & Growth Focused Investment Plans - Newser
Alzamend Neuro Inc. Hits Oversold Level on RSI IndicatorJuly 2025 Gainers & Advanced Technical Signal Analysis - beatles.ru
Alzamend Neuro Inc Stock (ALZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alzamend Neuro Inc Stock (ALZN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| AULT MILTON C III | Director |
Jul 30 '25 |
Sale |
2.51 |
29,449 |
73,982 |
108,260 |
| AULT MILTON C III | Director |
Jul 25 '25 |
Sale |
2.90 |
36,532 |
105,855 |
46,020 |
| AULT MILTON C III | Director |
Jul 28 '25 |
Sale |
2.68 |
8,311 |
22,314 |
37,709 |
| AULT MILTON C III | Director |
Jul 23 '25 |
Sale |
2.95 |
59,516 |
175,584 |
92,173 |
| AULT MILTON C III | Director |
Jul 24 '25 |
Sale |
2.93 |
9,621 |
28,237 |
82,552 |
| AULT MILTON C III | Director |
May 12 '25 |
Sale |
5.06 |
1,213 |
6,138 |
8,260 |
| AULT MILTON C III | Director |
May 12 '25 |
Sale |
5.28 |
11 |
58 |
1,843 |
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):